These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11476888)

  • 1. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse.
    Mirnics K; Middleton FA; Lewis DA; Levitt P
    Trends Neurosci; 2001 Aug; 24(8):479-86. PubMed ID: 11476888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.
    Pongrac J; Middleton FA; Lewis DA; Levitt P; Mirnics K
    Neurochem Res; 2002 Oct; 27(10):1049-63. PubMed ID: 12462404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental expression profiles of axon guidance signaling and the immune system in the marmoset cortex: potential molecular mechanisms of pruning of dendritic spines during primate synapse formation in late infancy and prepuberty (I).
    Sasaki T; Oga T; Nakagaki K; Sakai K; Sumida K; Hoshino K; Miyawaki I; Saito K; Suto F; Ichinohe N
    Biochem Biophys Res Commun; 2014 Feb; 444(3):302-6. PubMed ID: 24485715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing schizophrenia by DNA microarrays.
    Horváth S; Janka Z; Mirnics K
    Biol Psychiatry; 2011 Jan; 69(2):157-62. PubMed ID: 20801428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of cDNA microarrays to examine gene expression differences in schizophrenia.
    Vawter MP; Barrett T; Cheadle C; Sokolov BP; Wood WH; Donovan DM; Webster M; Freed WJ; Becker KG
    Brain Res Bull; 2001 Jul; 55(5):641-50. PubMed ID: 11576761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
    Mirnics K; Middleton FA; Marquez A; Lewis DA; Levitt P
    Neuron; 2000 Oct; 28(1):53-67. PubMed ID: 11086983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin.
    Bennett A O MR
    Aust N Z J Psychiatry; 2008 Aug; 42(8):662-77. PubMed ID: 18622774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.
    Gokhale A; Hartwig C; Freeman AH; Das R; Zlatic SA; Vistein R; Burch A; Carrot G; Lewis AF; Nelms S; Dickman DK; Puthenveedu MA; Cox DN; Faundez V
    J Neurosci; 2016 Dec; 36(49):12393-12411. PubMed ID: 27927957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.
    Mirnics K; Middleton FA; Stanwood GD; Lewis DA; Levitt P
    Mol Psychiatry; 2001 May; 6(3):293-301. PubMed ID: 11326297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray technology and its application on nicotine research.
    Li MD; Konu O; Kane JK; Becker KG
    Mol Neurobiol; 2002 Jun; 25(3):265-85. PubMed ID: 12109875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia.
    Lehrmann E; Hyde TM; Vawter MP; Becker KG; Kleinman JE; Freed WJ
    Curr Mol Med; 2003 Aug; 3(5):437-46. PubMed ID: 12942997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders.
    Neniskyte U; Gross CT
    Nat Rev Neurosci; 2017 Nov; 18(11):658-670. PubMed ID: 28931944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synaptogenesis and synaptic pruning: role in triggering schizophrenia].
    Granger B
    Presse Med; 1996 Nov; 25(33):1595-8. PubMed ID: 8952675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement System in Neural Synapse Elimination in Development and Disease.
    Presumey J; Bialas AR; Carroll MC
    Adv Immunol; 2017; 135():53-79. PubMed ID: 28826529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    Tkachev D; Mimmack ML; Ryan MM; Wayland M; Freeman T; Jones PB; Starkey M; Webster MJ; Yolken RH; Bahn S
    Lancet; 2003 Sep; 362(9386):798-805. PubMed ID: 13678875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroproteomics of schizophrenia.
    English JA; Pennington K; Dunn MJ; Cotter DR
    Biol Psychiatry; 2011 Jan; 69(2):163-72. PubMed ID: 20887976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
    Eastwood SL; Harrison PJ
    Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease.
    Marcotte ER; Srivastava LK; Quirion R
    Pharmacol Ther; 2003 Oct; 100(1):63-74. PubMed ID: 14550505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Presynaptic Group III mGluR Recruits Gβγ/SNARE Interactions to Inhibit Synaptic Transmission by Cone Photoreceptors in the Vertebrate Retina.
    Van Hook MJ; Babai N; Zurawski Z; Yim YY; Hamm HE; Thoreson WB
    J Neurosci; 2017 Apr; 37(17):4618-4634. PubMed ID: 28363980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies.
    Mimmack ML; Brooking J; Bahn S
    Biol Psychiatry; 2004 Feb; 55(4):337-45. PubMed ID: 14960285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.